Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): University Hospital Halle, Martin-Luther-University Halle-Wittenberg Background and purpose The dysfunctionality of endothelial cells (EC) and smooth muscle cells (SMC) contributes to the progression of vascular remodeling and subsequent cardiovascular pathologies. Several microRNAs (miRNA) have been revealed as key regulators of EC and SMC function, therefore suggesting them as potential targets in the modulation of vascular remodeling. Here, we investigate the potential role of miR-32-5p in vascular cell function and its potential as a therapeutic target in vascular remodeling. Material and Methods Initial screenings by qRT-PCR analysis for miR-32-5p expression were performed in murine femoral artery tissue on day 10 and 21 after wire-induced injury in C57Bl6 mice, serving as restenosis model. MiR-32-5p expression was assessed using qRT-PCR in human vascular endothelial (HVECs) and human vascular smooth muscle cells (HVSMC). The role of miR-32-5p on cellular functions, as migration and proliferation, was determined by performing scratch wound and BrdU assays. Potential miR-32-5p downstream targets were identified from literature and their expression levels upon interference with miR-32-5p evaluated on mRNA and protein levels. Results MiR-32-5p expression was decreased over time in the wire-induced injury model. In vitro, miR-32-5p expression was significantly decreased in replicative senescent HVSMC and HVEC (p<0,05) and relatively higher in HVSMC than in HVEC for all conditions. Under growth conditions an elevated expression of miR-32-5p in HVEC and significantly increased expression in HVSMC was detected (p<0,01). Proliferation in HVSMC increased significantly (p<0,05) by pre-miR-32-5p transfection, but remained unaffected in HVEC. Migration of HVECs and HVSMCs was improved by miR-32-5p and decelerated after antagomiR interference. Systemic literature target research revealed several potential targets in both cell types, of which the following were significantly downregulated in HVSMC after pre-miR transfection including PIK3r3 (p<0,05), KLF4 (p<0,05), CD69 (p<0,01), MAP2K4 (p<0,05) and BCL211 (p<0,01). Additionally, CD69 and KLF4 expression increased significantly either in HVECs (p<0,05). Conclusion Our results suggest that miR-32-5p may be a substantial regulator in HVEC and HVSMC senescence and function and subsequently in vascular remodeling. To fully evaluate its role in the pathogenesis of atherosclerosis and therefore, its therapeutic potential in cardiovascular diseases, further investigations are needed. Additional experiments with the purpose of investigating miR-32-5p-target interactions and apoptotic effects will be performed shortly.

Flow-Regulation Of Vascular Smooth Muscle Cell Proliferation: Roles Of Endothelial Cell-Secreted Microrna-126

Role of Specific Micrornas for Endothelial Function and Angiogenesis

Abstract 162: MicroRNAs Mediate the Hemodynamic Regulation of Endothelium-to-Smooth Muscle Signaling

Regulation of Vascular Smooth Muscle Cell Turnover by Endothelial Cell-Secreted Microrna-126: Role of Shear Stress

Regulation of Vascular Smooth Muscle Cell Turnover by Endothelial Cell–Secreted MicroRNA-126

VAMP3 and SNAP23 Mediate the Disturbed Flow-Induced Endothelial Microrna Secretion and Smooth Muscle Hyperplasia.

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

MicroRNAs As Potential Novel Therapeutic Targets and Tools for Regulating Paracrine Function of Endothelial Progenitor Cells

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

Role of Microrna-23B in Flow-Regulation of Rb Phosphorylation and Endothelial Cell Growth

Mechanoresponsive Smad5 Enhances MiR-487a Processing to Promote Vascular Endothelial Proliferation in Response to Disturbed Flow

The Feedback Regulation of PI3K-miR-19a, and MAPK-miR-23b/27b in Endothelial Cells under Shear Stress

MicroRNA-19a Mediates the Suppressive Effect of Laminar Flow on Cyclin D1 Expression in Human Umbilical Vein Endothelial Cells

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Extracellular Vesicles Mediate Communication between Endothelial and Vascular Smooth Muscle Cells

Microrna-10a Is Crucial For Endothelial Response To Different Flow Patterns Via Interaction Of Retinoid Acid Receptors And Histone Deacetylases

Flow-Dependent Regulation of Kruppel-Like Factor 2 is Mediated by Microrna-92a

MicroRNA-92 regulates vascular smooth muscle cell function by targeting KLF4 during vascular restenosis and injury

MiR-140-3p Normalizes Vascular Smooth Muscle Cell Behavior by Inhibiting the RhoA/ROCK Signaling Pathway in Lower-extremity Arteriosclerosis Obliterans

MiR-32-5p as potential key mediator of vascular remodeling enhances cell proliferation of vascular smooth muscle cells

MicroRNA-21 Targets Peroxisome Proliferators-Activated Receptor-Α in an Autoregulatory Loop to Modulate Flow-Induced Endothelial Inflammation